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X-ray protein crystallography has, through the determination of the three-
dimensional structures of enzymes and their complexes, been essential to the
understanding of biological chemistry. However, as X-rays are scattered by
electrons, the technique has difficulty locating the presence and position of H
atoms (and cannot locate H+ ions), knowledge of which is often crucially
important for the understanding of enzyme mechanism. Furthermore, X-ray
irradiation, through photoelectronic effects, will perturb the redox state in the
crystal. By using single-crystal spectrophotometry, reactions taking place in the
crystal can be monitored, either to trap intermediates or follow photoreduction
during X-ray data collection. By using neutron crystallography, the positions of
H atoms can be located, as it is the nuclei rather than the electrons that scatter
neutrons, and the scattering length is not determined by the atomic number.
Combining the two techniques allows much greater insight into both reaction
mechanism and X-ray-induced photoreduction.
1. Introduction
In biological processes, enzymes act as catalysts to increase the
rate of reaction. These reactions always involve changes in
energy and electron configurations. To understand these
processes, we also need to be able to know the location of H
atoms and how they are transferred between macromolecules,
substrates and solvent molecules. The textbook energy profile
of a reaction will show peaks of transition states (of the highest
energy or least stability) and troughs of intermediates (more
stable than the transition states but still less stable than
reactants or products). Unfortunately, this means that the
most interesting states are the least stable and the hardest to
study. For crystal structures to report on mechanism we need
to establish how we can isolate and monitor intermediates in
the crystal; this monitoring has to be able to not only establish
that a trapped intermediate is stable during the time taken for
crystallographic structure determination but also that the
process of data collection itself does not change it. A clear
understanding of the chemistry of an enzymatic reaction also
needs knowledge of the positions of H atoms. Furthermore,
computational analysis and simulations of enzyme mechan-
isms require a full description of hydrogen positions.
2. Finding H atoms
X-ray crystallography relies on the scattering of X-rays by
electrons; the scattering from an individual atom or ion is
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proportional to the number of electrons that it has. For
crystallographic calculations the atomic electron density is
described as a two-term or five-term Gaussian distribution [for
further discussion, see the write-up for the CCP4 program
SFALL (http://www.ccp4.ac.uk/html/sfall.html) and Interna-
tional Tables for Crystallography (2006)]. The neutral H atom
has only one electron, but this will be shared when covalently
bonded to a heavier atom; a positive hydrogen ion would have
no electrons at all, although a discrete H+ ion will only have an
evanescent existence. The problem of weak density is further
compounded by the short length of a bond to an H atom
(typically 1.1 A˚), so resolving the very weak hydrogen
electron density from a bonded ‘heavy’ (i.e. non-H) atom
requires sub-a˚ngstrom data. Difference maps calculated using
sub-a˚ngstrom data clearly do show density from H atoms (for
a recent review of what can be seen at atomic resolution, see
Neumann & Tittmann, 2014). Unfortunately, such data are not
often available. When errors and the smearing effects of
atomic displacement are considered, it is not safe to assume
that an absence of density correlates to the absence of a
hydrogen at a point (for an example, see Fig. 1). The high
X-ray dose required to obtain atomic resolution data may also
have an effect on the chemistry of the protein being studied
(see x3.2).
2.1. Derived H-atom positions
In the absence of atomic resolution X-ray data, some useful
information may be derived by careful analysis of the chem-
istry and bond lengths of heavy atoms. If the electronic
configuration of an atom can be confidently deduced, it may
be possible to extrapolate the positions of H atoms. For
example, the positions of the methylene H atoms of an sp3
tetrahedral C atom can be extrapolated from the direction of
the bonds to adjacent heavy atoms. Of course this will not
work if the protonation state is unknown. In the case of a
carboxylic acid group, differing bond lengths between the O
atoms and the carbon would indicate protonation and distin-
guish C O from C—OH. The sensitivity of difference Fourier
methods gives this a power beyond what might be expected
from the resolution of the data (Ahmed et al., 2007).
2.2. Neutron crystallography
Neutrons of suitable energy (thermal neutrons) have de
Broglie wavelengths (de Broglie, 1924) that are similar to
those of X-rays; thus, a beam of neutrons can be used, like
X-rays, to determine the three-dimensional structures within
crystals. Unlike X-rays, neutrons are scattered by the nuclei
rather than the electrons. The scattering cross-sections for
neutrons depend on the nuclear rather than electron density
(see Table 1). A consequence of this is that deuterium, with
a positive scattering length, is easily distinguished from
hydrogen (with a negative scattering length) and is of similar
magnitude to the other atoms in biological macromolecules.
Neutron crystallography therefore allows the direct observa-
tion of hydrogen and deuterium. Obtaining neutron crystallo-
graphic data is not, however, trivial. It is very slow, especially
compared with X-ray data collection at a third-generation
synchrotron (with individual exposures taking hours), and it
requires large crystals of the order of 1 mm3 and a source of
thermal neutrons such as a nuclear reactor or spallation
source.
The H atoms themselves also present complications. The
negative scattering length of hydrogen (Table 1) is about half
of the positive value for carbon, so the sum of a methylene
(–CH2–) group will be near zero and, at medium to low
resolution, this may be seen as a break in density. However, by
also collecting X-ray diffraction data it is possible to refine
structures simultaneously against both X-ray and neutron
data. This is implemented in PHENIX and as a patch for CNS
(nCNS; Adams et al., 2009). Although the CCP4 libraries do
include the nuclear scattering factors, refinement with neutron
data using the CCP4 suite is not straightforward. H atoms also
have a very large incoherent cross-section, meaning that they
contribute very strongly to the background noise in the
diffraction images. However, it is possible to replace the
exchangeable protons by equilibrating with D2O and, by
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Figure 1
Absence of evidence is not evidence of absence. 0.9 A˚ resolution X-ray
structure of a phenylalanine residue in PETN reductase (model and data
from PDB entry 1vyr; Barna et al., 2001) showing that even though some
H atoms can be seen, those that are known to be present are not always
observed (at one meta and the para positions in this case). The electron
density is calculated excluding H atoms, the pink density is 2Fo  Fc
density contoured at 3.0 and the green density which shows both H
atoms at the ortho position but only one at the meta position is Fo  Fc
density contoured at 3.0. H atoms are shown in green.
Table 1
Atomic number (Z) and nuclear scattering lengths of common atoms
found in biological structures.
Values are taken from Myles (2006).
Atom Z
Incoherent
cross-section (barns)
Coherent scattering
length (1012 cm)
1H 1 80.2 0.374
2D 1 2.05 0.667
12C 6 0.00 0.665
14N 7 0.49 0.937
16O 8 0.00 0.580
32S 16 0.00 0.28
56Fe 26 0.00 1.012
producing recombinant protein from a deuterated carbon
source (Shu et al., 2000), the non-exchangeable H atoms can
also be replaced. The lack of radiation damage (see x3.2.3) by
thermal neutrons means that it has been normal practice to
collect data at room temperature from crystals mounted in
capillaries in the manner that was used for X-ray data
collection before the use of cryoconditions became standard.
Although this avoids problems arising from icing over long
exposure times, it is unsuitable for studying labile inter-
mediates that require cryo-trapping.
The power of neutron crystallography to show hydrogen
positions and thus to understand enzyme mechanism is illu-
strated by the example of histidine. The side chain of this
amino acid includes an imidazole ring with a pKa near
neutrality. The ability of this group to accept and donate
protons is key to its involvement in enzymatic catalysis. This
of course includes the famous ‘catalytic triad’ of the serine
proteases (Matthews et al., 1967). By H/D exchange with D2O
the imidazole group will be either neutral and singly deuter-
ated or positively charged and doubly deuterated. The nuclear
density of these clearly shows the different ionization states
(Fig. 2a and 2b). Water, which appears as a sphere of electron
density from the O atom in X-ray data-derived maps, when
substituted by D2O shows as a ‘banana’ shape in the neutron
maps (Fig. 2c). These observations allow hydrogen bonds to be
assigned with confidence. For a fuller discussion of neutron
protein crystallography, see Blakeley et al. (2015) and O’Dell
et al. (2016).
3. Catching and verifying intermediates
As the most catalytically relevant and therefore informative
states of the reaction pathway of an enzyme are expected to be
the least stable, ways have to be found to follow reactions in
the crystal and then to manipulate conditions such that these
interesting states can be trapped and maintained for structural
study.
3.1. Single-crystal spectroscopy
The usual method of studying enzyme reactions in solution
is by electronic absorption or fluorescence spectroscopy in the
UVor visible range. As a reaction proceeds and a substrate or
cofactor changes its electronic state, its spectral signature
changes, and in favourable cases this can be followed and
analysed. The classic example is the increase in the 340 nm
absorbance of NAD(P)H over NAD(P) that is used to follow
dehydrogenase reactions (Krimsky & Racker, 1955).
This principle can be applied to crystals as well as solution,
although there are some practical difficulties that need to be
considered. The relatively small size of crystals means that the
light beam needs to have an appropriately small cross-section;
this is usually achieved by focusing optics. If the effects of
irradiation are to be followed, it is important to have the same
part of the crystal illuminated as is irradiated (a co-axial
solution to this problem is described in Owen et al., 2009). A
crystal may act as a prism, refracting different wavelengths
anisotropically and altering the spectrum as the crystal is
rotated. The high concentration of protein in the crystal may
result in the optical density of some features of the spectrum
being very high and therefore noisy or unmeasurable (e.g. the
Soret band in haem proteins).
A notable early achievement of the technique was to
demonstrate that enzyme crystals are catalytically active,
relieving anxieties that the process of crystallization somehow
made them unphysiological, which would have meant that
X-ray crystal structures of proteins would have been of little
value. Rossi and Bernhard first used single-crystal spectro-
scopy to verify that the reactions of a chromophoric derivative
of chymotrypsin are the same in the crystal as in solution
(Rossi & Bernhard, 1970). Later, the turnover of glycer-
aldehyde 3-phosphate dehydrogenase in
a crystal mounted in a flow cell was
characterized by following the NAD/
NADH 340 nm changes spectrophoto-
metrically (Vas et al., 1979), establishing
the validity of crystal structures as
representing catalytically active confor-
mations of the protein. The standard
technique of collecting data at 100 K
means that once intermediates have
been formed in the crystal, they can be
cryo-trapped for structure determina-
tion. Combining the spectroscopic
monitoring of intermediate states has
allowed time-resolved determinations
of the structures of enzyme catalytic
intermediates (reviewed by Hajdu et al.,
2000). A recent example of the appli-
cation of the techniques to ‘snapshot’
reaction steps in a dehydrogenase is
described by Huo et al. (2015). Single-
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Figure 2
Comparison of calculated nuclear and electron densities at 2.0 A˚ resolution. Nuclear and electron
densities are shown in cyan and magenta, respectively. (a) Nuclear and electron density for a
tautomer of neutral histidine where N1 is deuterated. The negative scattering of the two H atoms
bonded to the C of the side chain has cancelled out the nuclear density at this point. (b) Nuclear
and electron density for a tautomer of positively charged histidine where both N1 and N"2 are
deuterated. (c) Nuclear and electron density calculated for a water molecule. All densities are
contoured at 2. The densities were calculated in PHENIX (Adams et al., 2009). H and D atoms are
shown in green and white, respectively.
crystal spectroscopy facilities have been installed on
synchrotron beamlines and expanded from UV–Vis absor-
bance to include fluorescence and Raman spectroscopy. The
current status and availability of these resources are reviewed
extensively in the proceedings of the 2014 CCP4 Study
Weekend (Dworkowski et al., 2015; von Stetten et al., 2015).
3.2. Photoreduction
Collecting X-ray data at 100 K may catch unstable inter-
mediates for study, but it does not prevent the primary
photoreduction events caused by ionizing radiation during
data collection, nor does the low temperature prevent the
movement of electrons. Radiation-induced damage in protein
crystals has been described and reviewed extensively by
Garman (2010). The chemical activity of the catalytic
processes in an enzyme means that these are especially
vulnerable to perturbation. X-ray photons have energies in
the range 6–20 keV, about 1000 times the electron first ioni-
zation energy of most atoms (between 4 and 16 eV). The
X-ray photons will cause the ejection of electrons from atoms
(Einstein, 1905; Meitner, 1922). Ejected electrons may travel
considerable distances within the protein structure and are
attracted to electrophilic centres in redox enzymes. There are
many examples of structures in the PDB that are described as
having a particular oxidation state but have most probably
been reduced to a greater or lesser extent during data
collection. If the spectrum from the crystal (or irradiated
portion of the crystal) is monitored during data collection, it
becomes possible to be confident of the redox state of the
structure being determined.
3.2.1. The example of flavoenzymes. The flavoenzymes
provide an interesting example whereby very few deposited
structures have had their redox states verified during or after
data collection. The ‘butterfly bend’ of the flavin (the dihedral
angle between the planes formed by the pyrimidine and
research papers
144 Kwon et al.  Combining X-ray and neutron crystallography with spectroscopy Acta Cryst. (2017). D73, 141–147
Figure 3
The effects of photoreduction in PETN reductase. (a) A crystal in the oxidized form, the spectrum and the near-planar electron density of the
isoalloxazine ring of the FMN molecule. (b) A crystal that has been reduced by X-ray data collection, the resulting spectrum and the bent isoalloxazine
ring of the FMN. 2Fo  Fc electron density contoured at 2 is shown as a blue mesh. Crystallization conditions are shown in Table 2, data-collection
statistics are shown in Table 3 and refinement statistics are shown in Table 4.
benzene rings of the isoalloxazine moiety) depends on the
oxidation state, with the oxidized form being flat and reduc-
tion inducing a bend along the N5–N10 axis (Fig. 3). Any
discussion of enzyme mechanism deduced from the structure
clearly needs to be in the context of the oxidation state
observed. The photoreduction of the flavin in an FMN-
containing enzyme during X-ray data collection was followed
by Røhr et al. (2010), showing the flavin bend. We also
observed this effect in crystals of PETN reductase; Fig. 3
shows the difference between the yellow colour of the
oxidized enzyme and the colourless X-ray reduced form, and
the spectra from the two crystal states. By monitoring the
crystal spectrum after varying X-rays doses we were able to
use a multi-crystal strategy to obtain a minimally reduced
structure and compare this with the X-ray reduced structure,
showing clearly that caution is required when interpreting
structures that have not been validated with spectroscopy.
Many of the structures of flavoenzymes in the PDB appear to
have used the restraints for the oxidized flavins (FAD and
FMN) in the refinement, even when the authors believe they
have the reduced form (and so should use the FDA or FNR
monomer library entries). The limited and inconsistent
descriptions within the CCP4 monomer libraries (http://
www.ccp4.ac.uk/html/lib_list.html) may add to the confusion.
3.2.2. The example of haem peroxidases. The haem
peroxidase reaction has two intermediate states (compound I
and compound II) where the haem iron is in the highly
oxidized ferryl (FeIV) state (Kwon et al., 2016). In order to
fully understand the reaction, it is necessary to determine
whether these intermediates are protonated, i.e. FeIV O or
FeIV—OH. It is possible to monitor the formation of the
intermediates spectroscopically and show that these are
sufficiently stable to be cryo-trapped (Gumiero et al., 2011).
Furthermore, using single-crystal spectrophotometry it can be
shown that this can be performed in the crystal. Berglund et al.
(2002) determined the structures of horseradish peroxidase
intermediates and showed the changes in redox states during
X-ray data collection. This was performed by careful moni-
toring and merging together of data from several crystals with
differing levels of exposure. In the case of cytochrome c
peroxidase, early work on the compound I intermediate
reported varying Fe—O distances of 1.7–1.9 A˚ (Fu¨lo¨p et al.,
1994) and 1.87 A˚, suggesting Fe—OH (Bonagura et al., 2003).
However, subsequent work using the low-dose multi-crystal
approach showed that the distance was 1.63 A˚ (Gumiero et al.,
2011), consistent with Fe O. Comparing the structures
derived from crystals with increasing doses showed a steadily
increasing distance to 2.0 A˚ (Gumiero, 2011). The use of
distance to extrapolate bond order and therefore protonation
state has to be treated with caution. Incomplete, low-
resolution or poor-quality data, as well as incomplete models
or high B values, will increase the uncertainties in atomic
positions (Murshudov & Dodson, 1997). A reasonable
research papers
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Table 2
Crystallization conditions for PETN reductase.
Method Vapour diffusion
Plate type Sitting drop
Temperature (K) 298
Protein concentration (mg ml1) 10
Buffer composition of protein
solution
50 mM potassium phosphate pH 7.0
Composition of reservoir solution 25% PEG 3000, 0.1M sodium citrate,
0.1M cacodylate pH 6.2, 17%
2-propanol
Volume and ratio of drop 4 ml, 1:1
Volume of reservoir (ml) 500
Table 4
Structure solution and refinement for oxidized and reduced PETN
reductase.
Values in parentheses are for the outer shell.
Oxidized
(PDB entry 5lgx)
Reduced
(PDB entry 5lgz)
Resolution range (A˚) 20.82–1.49 (1.53–1.49) 12.49–1.50 (1.52–1.50)
Completeness (%) 94.0 (79.2) 96.1 (85.0)
 Cutoff None None
No. of reflections
Working set 50507 (3118) 54130 (2241)
Test set 2715 (163) 2748 (127)
Final Rcryst 0.16 (0.26) 0.14 (0.18)
Final Rfree 0.20 (0.28) 0.18 (0.21)
No. of non-H atoms
Protein 2927 2976
Ligand 47 39
Water 618 673
Total 3592 3688
R.m.s. deviations
Bonds (A˚) 0.014 0.016
Angles () 1.41 1.36
Average B factors (A˚2)
Protein 9.21 10.9
Ligand 25.7 7.5
Water 24.0 26.5
Ramachandran plot
Most favoured (%) 97 96
Allowed (%) 3 4
Table 3
Data-collection and processing statistics for oxidized and reduced PETN
reductase.
Values in parentheses are for the outer shell.
Oxidized
(PDB entry 5lgx)
Reduced
(PDB entry 5lgz)
Diffraction source Rotating anode Rotating anode
Wavelength (A˚) 1.5418 1.5418
Temperature (K) 100 100
Crystal-to-detector distance (mm) 40 40
Rotation range per image () 0.5 0.5
Total rotation range () First 60 per
crystal  3
180
Exposure time per image (s) 30 30
Space group P212121 P212121
a, b, c (A˚) 56.69, 68.64, 88.60 56.85, 68.65, 88.93
, ,  () 90.0, 90.0, 90.0 90.0, 90.0, 90.0
Resolution range (A˚) 20.82–1.49
(1.52–1.49)
21.51–1.50
(1.53–1.50)
Total No. of reflections 252795 223446
No. of unique reflections 53305 54598
Completeness (%) 94.3 (76.5) 96.8 (88.1)
Multiplicity 4.7 (3.0) 4.1 (3.0)
hI/(I)i 10.1 (2.3) 11.7 (3.0)
Rmeas 0.15 (0.61) 0.08 (0.44)
Overall B factor from Wilson
plot (A˚2)
5.6 4.5
estimate of this positional uncertainty (ESU) requires the data
to be of sufficient resolution to be able to calculate a full
matrix inversion in SHELX (Sheldrick, 2008). Furthermore, in
the case of adjacent atoms with very different electron
densities [e.g. iron (Z = 26) and oxygen (Z = 8) in this case]
series-termination errors in the Fourier transform may intro-
duce significant shifts in atomic positions (Fu¨lo¨p et al., 2000).
3.2.3. Neutron crystallography of haem peroxidases.
Neutron crystallography has the advantage of being able to
directly observe H or D atoms and does not induce photo-
reduction. The haem-containing oxygen-binding protein
myoglobin was one of the earliest to be studied by neutron
crystallography, showing for the first time the iron–histidine
hydrogen bond directly (Phillips & Schoenborn, 1981).
Recently, neutron crystallography has been used to resolve the
catalytic mechanism of the haem peroxidases by the direct
observation of H atoms. By reacting crystals (as before) that
have been soaked in D2O to exchange H/D and verifying the
intermediate formation and stability at 100 K with single-
crystal spectroscopy and EPR, neutron crystallography could
be undertaken on compound I and compared with ferric
cytochrome c peroxidase. Owing to the moderate resolution of
the structures and as only the exchangeable H atoms were
replaced by deuterium, it was necessary to include X-ray data
in the refinement using PHENIX (Adams et al., 2009) to
position the methylene groups. Neutron crystallography
clearly showed that ferryl O atom was unprotonated, and
showed the ionization states of the histidine residues (Casadei
et al., 2014). The unexpected observation that the distal
histidine was doubly deuterated meant that the mechanism
has had to be re-evaluated (Groves & Boaz, 2014).
3.2.4. Neutron crystallography in other enzymes. Although
the cytochrome c peroxidase example above is the first use of
the combination of cryo-trapping intermediates and neutron
crystallography, neutron crystallography has, by placing H
atoms, provided insight into other enzyme mechanisms.
Recent examples include showing the movement of hydrogen
in the reaction of xylose isomerase (Kovalevsky et al., 2010),
the protonation state of the bound substrate in urate oxidase
(Oksanen et al., 2014) and the details of the interactions of a
clinical inhibitor of HIV-1 protease (Weber et al., 2013). A
notable early example is the demonstration of the doubly
protonated state of the catalytic histidine residue (and
therefore its role as a base in the hydrolysis reaction) in the
serine protease trypsin, resolving a longstanding controversy
about the role of the Asp–His pair of the catalytic triad
(Kossiakoff & Spencer, 1980, 1981). Bau (2005) reviews the
insight gained from this and other examples.
4. Concluding remarks
Single-crystal spectroscopy can allow the monitoring and
validation of intermediate catalytic states in the crystal. In
favourable circumstances these can be cryo-trapped and the
structures determined. Single-crystal spectroscopy is also
useful to monitor crystals for photoreduction during X-ray
data collection. X-ray crystallography does not directly give
the positions of H atoms, but neutron crystallography does.
Neutron crystallography also does not induce photoreduction.
However, neutron crystallography is not as accessible as
X-ray crystallography. A carefully considered combination of
methods is likely to be the best approach to understanding
biological chemistry through structure, and new techniques
(such as X-ray free-electron lasers) will increase the scope of
what can be discovered.
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